In 2024, 26.5% of adults with diagnosed diabetes used glucagon-like peptide 1 receptor agonist (GLP-1 RA) injectables.

For individuals with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a slightly increased risk for incident diabetic retinopathy (DR) and with a ...

Dentists claim weight-loss drugs could majorly impact users' saliva glands, helping gum disease to fester in their mouths.

A growing number of patients claim popular weight loss and diabetes drugs like Ozempic can cause a rare but very serious side ...

The latest results from a trial of a pill form popular GLP-1 medications offer enough information for the Eli Lilly to ...

New data from Eli Lilly says its daily, oral GLP-1 pill may help people who have obesity and people who have Type 2 diabetes ...

In a recent video spot, the 43-year-old athlete reveals that Ro helped her lose 31 pounds in eight months. “Yes, I’m on Ro.

Diabetes is well known to be associated with an increased cardiovascular risk. Although much of the evidence has been ...

The small study followed patients for six months and found that 54 percent experienced a reduction in their symptoms after taking a GLP-1RA. Most of the patients had type 2 diabetes and the median BMI ...